TY  - JOUR
AU  - Herrmann, Ken
AU  - Walz, Jochen
AU  - MacLennan, Steven
AU  - Briganti, Alberto
AU  - Cornford, Philip
AU  - Czernin, Johannes
AU  - Eiber, Matthias
AU  - Fanti, Stefano
AU  - Fendler, Wolfgang P
AU  - Fizazi, Karim
AU  - Gafita, Andrei
AU  - Gillessen, Silke
AU  - Goffin, Karolien
AU  - Hadaschik, Boris
AU  - Hofman, Michael S
AU  - Hope, Thomas A
AU  - Maurer, Tobias
AU  - Morgans, Alicia K
AU  - Morris, Michael J
AU  - Murphy, Declan G
AU  - Oprea-Lager, Daniela E
AU  - Ost, Piet
AU  - ÓSullivan, Joe M
AU  - Rouvière, Olivier
AU  - Sandhu, Shahneen
AU  - Sartor, Oliver
AU  - Sathekge, Mike Machaba
AU  - Tempany, Clare
AU  - Witjes, Wim
AU  - Emmett, Louise
AU  - Bjartell, Anders S
TI  - SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis.
JO  - European urology
VL  - nn
SN  - 0302-2838
CY  - Amsterdam [u.a.]
PB  - Elsevier Science
M1  - DKFZ-2025-01908
SP  - nn
PY  - 2025
N1  - epub
AB  - Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) is an evolving diagnostic tool for prostate cancer. There is a need to harmonise existing guidelines and reporting recommendations for PSMA PET/CT. The Standardised PSMA PET/CT Analysis and Reporting Consensus (SPARC) project aims to consolidate classifications and recommendations by a multidisciplinary and international group of experts under one cohesive framework, establishing a dynamic and evolving structure for PSMA PET/CT reporting.We employed a cross-sectional iterative process to define opinions and evaluate consensus. Thirty expert panel members, representing diverse specialities and geographic areas, were selected. A methods expert led the design, data collection, and analysis. Five groups of international multidisciplinary prostate cancer experts convened for literature review and formulation of statements on standardised reporting, detection, primary staging, biochemical recurrence, and treatment response. The groups compiled 91 statements for a two-round modified Delphi survey. The 'RAND appropriateness method' was used for the analysis.Consensus increased to 93
KW  - Positron emission tomography/computed tomography (Other)
KW  - Prostate cancer (Other)
KW  - Prostate-specific membrane antigen (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:40945999
DO  - DOI:10.1016/j.eururo.2025.08.005
UR  - https://inrepo02.dkfz.de/record/304585
ER  -